Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

Journal of Virology

Volumn 74, Issue 10, 2000, Pages 4652-4657

  Schlereth, Bernd ^a   Rose, John K ^b   Buonocore, Linda ^b   Ter Meulen, Volker ^a   Niewiesk, Stefan ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROCONVERSION; VESICULAR STOMATITIS VIRUS; VIRUS HEMAGGLUTINATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; DISEASE MODELS, ANIMAL; HEMAGGLUTININS, VIRAL; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION, PASSIVE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; NEUTRALIZATION TESTS; RATS; SIGMODONTINAE; VACCINATION; VACCINES, SYNTHETIC; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0034002848     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.10.4652-4657.2000     Document Type: Article

References (18)

1. Aaby, P., T. Jensen, and H. Hansen. 1988. Trial of high dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet ii:809-811.
2. Aaby, P., K. Knudsen, H. Whittle, et al. 1993. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J. Pediatr. 122:904-908.
3. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235-270.
4. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
5. Clements, C. J., and F. T. Cutts. 1995. The epidemiology of measles: thirty years of vaccination. Curr. Top. Microbiol. Immunol. 191:13-33.
6. Griffin, D. E. 1995. Immune responses during measles virus infection. Curr. Top. Microbiol. Immunol. 191:117-134.
7. Halsey, N. 1993. Increased mortality following high titer measles vaccines: too much of a good thing. Pediatr. Infect. Dis. J. 12:462-465.
8. Katz, S. L., and B. G. Gellin. 1994. Measles vaccine: do we need new vaccines or new programs. Science 265:1391-1392.
9. Niewiesk, S., I. Eisenhuth, A. Fooks, J. C. S. Clegg, J.-J. Schnorr, S. Schneider-Schaulies, and V. ter Meulen. 1997. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J. Virol. 71:7214-7219.
10. Roberts, A. J., L. Buoconore, R. Price, J. Forman, and J. K. Rose. 1999. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:3723-3732.
11. Roberts, A. J., E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buoconore, V. Kawaoka, and J. K. Rose. 1998. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72: 4704-4711.
12. Samb, B., P. Aaby, H. C. Whittle, A. M. Seck, S. Rahman, J. Bennett, L. Markowitz, and F. Simondon. 1995. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr. Infect. Dis. J. 14:203-209.
13. Sato, H., P. Albrecht, D. W. Reynolds, S. Stagno, and F. A. Ennis. 1979. Transfer of measles, mumps and rubella antibodies from mother to infant. Its effect on measles, mumps and rubella immunization. Am. J. Dis. Child. 133:1240-1243.
14. Schnell, M. J., L. Buonocore, E. Kretzschmar, E. Johnson, and J. K. Rose. 1996. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl. Acad. Sci. USA 93:11359-11365.
15. Schoub, B. D., S. Johnson, J. M. McAnerney, L. A. Wagstaff, W. Matsie, S. G. Reinach, et al. 1990. Measles, mumps and rubella immunisation at nine months in a developing country. Ped. Infect. Dis. J. 9:263-267.
16. van Binnendijk, R. S., M. C. M. Poelen, G. van Amerongen, P. de Vries, and A. D. M. E. Osterhaus. 1997. Protective immunity in macaaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175:524-532.
17. Whittle, H., P. Hanlon, K. O'Neil, L. Hanlon, V. Marsh, and E. Jupp. 1988. Trial of high-dose Edmonston-Zagreb measles vaccine in Gambia: antibody response and side-effects. Lancet 11:811-814.
18. Wyde, P. R., M. W. Ambrosi, T. G. Voss, H. L. Meyer, and B. F. Gilbert. 1992. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc. Soc. Exp. Biol. Med. 201:80-87.